title: Characterization of myosin V from PC12 cells.
abstract: PC12 cell line is a cellular model to study neurite outgrowth and neurotransmitter release mechanisms. Molecular motors may be involved in these responses and myosin V could be a candidate to mediate these effects. Overlay experiments using [(125)I]-calmodulin showed that PC12 cells possess several calmodulin-binding proteins, some of them around 190-210 kDa. Western blots using affinity purified polyclonal antibodies raised against chicken brain myosin V revealed a component of 190 kDa, a molecular mass typical of myosin V. Furthermore, Northern blots using a myosin V probe also detected a transcript of around 12 kbp. Immunofluorescence cytochemistry demonstrated the localization of myosin V throughout the cytoplasm, in the neurites, growth cone tips, and with an intense asymmetrical perinuclear labeling. Western blot analyses of PC12 cellular extracts after FGF-2 and/or dibutyryl cAMP treatment revealed variations between myosin V and myosin II expression during neuronal differentiation. These results demonstrated the presence of myosin V in PC12 cells and also suggest a role for this motor molecule in the neuronal differentiation response in PC12 cells.
authors.affiliation: Centro de Biotecnologia, Instituto Butantan, São Paulo, SP, 05503-900, Brazil.
authors.forename: P
authors.initials: P
authors.lastname: Wolff
authors.forename: P A
authors.initials: PA
authors.lastname: Abreu
authors.forename: E M
authors.initials: EM
authors.lastname: Espreafico
authors.forename: M C
authors.initials: MC
authors.lastname: Costa
authors.forename: R E
authors.initials: RE
authors.lastname: Larson
authors.forename: P L
authors.initials: PL
authors.lastname: Ho
mesh_terms: D000818:Animals; D015153:Blotting, Western; D003994:Bucladesine / Q000494:pharmacology; D002147:Calmodulin / Q000378:metabolism; D002148:Calmodulin-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation / Q000187:drug effects; D020439:Growth Cones / Q000187:drug effects / Q000378:metabolism; D008970:Molecular Weight; D024701:Myosin Type V; D009218:Myosins / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D016501:Neurites / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D016716:PC12 Cells; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D051381:Rats
chemical_list: D002147:Calmodulin; D002148:Calmodulin-Binding Proteins; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; C078829:chicken brain myosin-V p190; D016222:Fibroblast Growth Factor 2; D003994:Bucladesine; D024701:Myosin Type V; D009218:Myosins